Access SEE 2023 – Volume 39B Electronic

Access SEE 2023 – Volume 39B Booklet

You can only access courses that you purchased or are complimentary.

To access all of your courses, log into My Courses. Or, via ASAHQ.org, using the main menu at the top of the website, choose “Education & CME,” then choose “My Courses.”

After successfully completing this activity, the learner will be able to:

• Explain emerging concepts in anesthesia practice, as presented in the current literature 
• Discuss the impact of emerging research on clinical practice
• Utilize this information to enhance his or her practice

Summaries of Emerging Evidence Editorial Board (SEE Volume 39B)

Wade A. Weigel, MD, FASA, Editor-in-Chief
Seattle, Washington

Neil A. Hanson, MD, Medical Editor
Edina, Minnesota

Alyssa B. Brzenski, MD
San Diego, California

Destiny F. Chau, MD
Little Rock, Arkansas

Gloria Cheng, MD
Dallas, Texas

Sung "Jason" Chi, MD
Mountain View, California

Bianca M. Conti, MD
Baltimore, Maryland

Natalie F. Holt, MD, MPH
Aberdeen, South Dakota

Aaron N. Primm, MD, FASA
New York, New York

Amy Robertson, MD
Nashville, Tennessee

Naileshni S. Singh, MD
Sacramento, California

Task Force Members (SEE Volume 39B)

Anita Akbar Ali, MD
Little Rock, Arkansas

Meenakshi Atteri, MD
Little Rock, Arkansas

Adrian N. Avila-Hernandez, MD
North Augusta, South Carolina

Philip Bailey, Jr, DO, FASA
Bala Cynwyd, Pennsylvania

J. Kyle Bohman, MD
Rochester, Minnesota

Victoria A. Bradford, MD, MBA
Lexington, Kentucky

Rachel M. Sloan Cancilla, MD
Brookhaven, Georgia

Jean Charchaflieh, MD, DrPH
New Haven, Connecticut

John R. Coleman, MD
Aylett, Virginia

M. Denise Daley, MD
Houston, Texas

Richard P. Dutton, MD, MBA, FASA
Fulton, Maryland

John H. Eisenach, MD, FASA
Westminster, Colorado

Regina Y. Fragneto, MD, FASA
Georgetown, Kentucky

Vijay K. Gaba, MD, FASA
Fargo, North Dakota

Meera Gangadharan, MD, FASA
Houston, Texas

Mary Beth Gibbons, MD
Covington, Kentucky

Mary Ann Gurkowski, MD, FASA
San Antonio, Texas

Robert L. Hsiung, MD, FASA
Seattle, Washington

Kristyn B. Ingram, MD
El Paso, Texas

Kelly Ivins-O’Keefe, MD
San Antonio, Texas

Norma J. Klein, MD
Sacramento, California

Tariq M. Malik, MD, FASA
Glenview, Illinois

John G. McNutt, MD
Ladera Ranch, California

Alexander Nguyen, MD
New York, New York

Vanessa A. Olbrecht, MD, MBA, FASA
Columbus, Ohio

Nathan L. Pace, MD, MStat
Salt Lake City, Utah

Nathan Painter, MD
Durham, North Carolina

Vikram P. Patel, MD, FASA
Collierville, Tennessee

Josiah N.J. Perez, MD
Seattle, Washington

Vidya T. Raman, MD, MBA, FAAP, FASA
Columbus, Ohio

Annette Rebel, MD, FASA
Pikeville, Kentucky

Barbara Rogers, MD, FASA
Powell, Ohio

Chinar D. Sanghvi, MD
Sacramento, California

Joseph Strunk, MD
Shoreline, Washington

Alex T. Suginaka, DO
Eau Claire, Wisconsin

Matthew N. Vogt, MD
Rochester, Minnesota

ASA Staff: Kari L. Lee, Senior Managing Editor; Ginger Clark, Managing Editor; Rachel Winokur, Senior Editor; Mark Grant, MD, PhD, Senior Methodologist

The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities. 

Disclosures (SEE Volume 39B) 

The following SEE faculty, staff, and/or planning committee members have indicated that they have relationships with ineligible companies to disclose:

Ginger Clark
Merck & Co, Inc—Stock
Organon & Co—Stock

Richard P. Dutton, MD, MBA, FASA
Medtronic—Independent Contractor – Consultant
Edwards Lifesciences—Independent Contractor – Consultant
Cerus Corporation—Independent Contractor – Data and Safety Monitoring

Nathan L. Pace, MD, MStat
Elute, Inc—Independent Contractor – Consultant

All relevant financial relationships for this activity have been mitigated.

All other planners, faculty, and staff have reported no relevant financial relationships with ineligible companies to disclose.